"Designing Growth Strategies is in our DNA"

Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100198

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Idiopathic Inflammatory Myopathy by Key Countries, 2018
    2. Advancements in Research & Development of Treatment Options
    3. Pipeline Analysis
    4. Key Industry Developments
    5. New Product Launches
  5. Global Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis, Insights and Forecast – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Disease Type
      1. Dermatomyositis (DM)
      2. Polymyositis (PM)
      3. Inclusion Body Myositis (IBM)
      4. Necrotizing Autoimmune Myopathy (NAM)
      5. Others
    3. Market Analysis – By Treatment
      1. Corticosteroids
      2. Immunosuppressants
      3. Intravenous Immunoglobulins
      4. Others
    4. Market Analysis – By Route of Administration
      1. Oral
      2. Intravenous
      3. Others
    5. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    6. Market Analysis – By Country/ Sub-Region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. immunoforge
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. ORPHAZYME A/S
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Biotest AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. CSL Limited (CSL Behring)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. Grifols, S.A.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Kedrion S.p.A
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. LFB Group
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Shire (Takeda Pharmaceutical Company Limited)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Pfizer Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Mylan N.V.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
Read Less

Figure 1: Global Idiopathic Inflammatory Myopathy Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2: Global Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018 & 2026

Figure 3: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Dermatomyositis (DM), 2015-2026

Figure 4: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Polymyositis (PM), 2015-2026

Figure 5: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Inclusion Body Myositis (IBM), 2015-2026

Figure 6: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Necrotizing Autoimmune Myopathy (NAM), 2015-2026

Figure 7: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8: Global Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018 & 2026

Figure 9: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Corticosteroids, 2015-2026

Figure 10: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Immunosuppressants, 2015-2026

Figure 11: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Intravenous Immunoglobulins, 2015-2026

Figure 12: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 13: Global Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 14: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 15: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Intravenous, 2015-2026

Figure 16: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 17: Global Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 18: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 19: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 20: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 21: Global Idiopathic Inflammatory Myopathy Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 22: Global Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 23: North America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 24: North America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018

Figure 25: North America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 26: North America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018

Figure 27: North America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 28: North America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018

Figure 29: North America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 30: North America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 31: North America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 32: North America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), By Country, 2018

Figure 33: Europe Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 34: Europe Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018

Figure 35: Europe Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 36: Europe Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018

Figure 37: Europe Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 38: Europe Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018

Figure 39: Europe Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 40: Europe Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 41: Europe Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 42: Europe Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 43: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 44: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018

Figure 45: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 46: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018

Figure 47: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 48: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018

Figure 49: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 50: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 51: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 52: Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 53: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 54: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018

Figure 55: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 56: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018

Figure 57: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 58: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018

Figure 59: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 60: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 61: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 62: Latin America Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 63: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 64: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Disease Type, 2018

Figure 65: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 66: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Treatment, 2018

Figure 67: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 68: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Route of Administration, 2018

Figure 69: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 70: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 71: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 72: Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 73: Global Idiopathic Inflammatory Myopathy Treatment Market Share (%), By Company, 2018

Table 1:   Global Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

 Table 2:   Global Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

 Table 3:   Global Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

 Table 4:   Global Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

 Table 5:   Global Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

 Table 6:   North America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

 Table 7:   North America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

 Table 8:   North America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

 Table 9:   North America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

 Table 10:   North America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

 Table 11:   Europe Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

 Table 12:   Europe Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

 Table 13:   Europe Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

 Table 14:   Europe Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

 Table 15:   Europe Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 Table 16:   Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

 Table 17:   Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

 Table 18:   Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

 Table 19:   Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

 Table 20:   Asia Pacific Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 Table 21:   Latin America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

 Table 22:   Latin America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

 Table 23:   Latin America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

 Table 24:   Latin America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

 Table 25:   Latin America Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

 Table 26:   Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

 Table 27:   Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

 Table 28:   Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

 Table 29:   Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

 Table 30:   Middle East & Africa Idiopathic Inflammatory Myopathy Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Idiopathic Inflammatory Myopathy Treatment Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase